We transcend borders, time zones, and especially the status quo to develop therapies that are more accessible to people around the world.

Learn More

Putting Patients First

Learn more about how we are working to discover and develop innovative medicines that are more accessible and affordable to patients around the world.

Science-Based, Passion-Driven

We are advancing an innovative, high-value product portfolio for patients globally.

Learn More
doctor_and_patient

Passion with Purpose

We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.

Learn More
people_walking

Our Commitment to Patients

We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”

Learn More
elder_women

BeiGene News

February 3, 2023

New Talk About It Resources Aim to Accelerate Integration of Mental Health into Quality Cancer Care

Read more

February 1, 2023

BeiGene to Present at Upcoming Investor Conferences

Read more

January 19, 2023

BRUKINSA® Approved in the U.S. for Chronic Lymphocytic Leukemia

Read more

January 19, 2023

BRUKINSA® (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRA

Read more

January 18, 2023

BeiGene Announces Expansion of Coverage on China’s National Reimbursement Drug List

Read more

January 17, 2023

BeiGene Presents New Research from Tislelizumab Global Development Program at 2023 ASCO Gastrointestinal Cancers Symposium

Read more